Sunzen Biotech Bhd Stock Net Income
| 0148 Stock | 0.32 0.01 3.23% |
Sunzen Biotech Bhd fundamentals help investors to digest information that contributes to Sunzen Biotech's financial success or failures. It also enables traders to predict the movement of Sunzen Stock. The fundamental analysis module provides a way to measure Sunzen Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sunzen Biotech stock.
Sunzen |
Sunzen Biotech Bhd Company Net Income Analysis
Sunzen Biotech's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Sunzen Biotech Net Income | 3.71 M |
Most of Sunzen Biotech's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sunzen Biotech Bhd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Sunzen Biotech Bhd reported net income of 3.71 M. This is much higher than that of the Consumer Non-Cyclicals sector and significantly higher than that of the Food & Tobacco industry. The net income for all Malaysia stocks is notably lower than that of the firm.
Sunzen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sunzen Biotech's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sunzen Biotech could also be used in its relative valuation, which is a method of valuing Sunzen Biotech by comparing valuation metrics of similar companies.Sunzen Biotech is currently under evaluation in net income category among its peers.
Sunzen Fundamentals
| Return On Equity | 2.91 | |||
| Current Valuation | 128.73 M | |||
| Price To Book | 1.22 X | |||
| Price To Sales | 1.34 X | |||
| Revenue | 90.48 M | |||
| EBITDA | 6.57 M | |||
| Net Income | 3.71 M | |||
| Total Debt | 5.08 M | |||
| Cash Flow From Operations | (16.36 M) | |||
| Market Capitalization | 147.73 M | |||
| Total Asset | 148.71 M | |||
| Z Score | 17.4 | |||
| Net Asset | 148.71 M |
About Sunzen Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sunzen Biotech Bhd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sunzen Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sunzen Biotech Bhd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Sunzen Stock
Sunzen Biotech financial ratios help investors to determine whether Sunzen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sunzen with respect to the benefits of owning Sunzen Biotech security.